Glycated Human Serum Albumin Isolated from Poorly Controlled Diabetic Patients Impairs Cholesterol Efflux from Macrophages: An Investigation by Mass Spectrometry

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Journal of Mass Spectrometry

• Publication date

  2015-04-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1255/ejms.1322PMID 26307703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA‐1‐mediated reverse cholesterol transport

  2013cited by this paper
• The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes.

  2012cited by this paper
• Inhibition of Macrophage Oxidative Stress Prevents the Reduction of ABCA-1 Transporter Induced by Advanced Glycated Albumin

  2012cited by this paper
• Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update

  2012cited by this paper
• Advanced glycated albumin impairs HDL anti-inflammatory activity and primes macrophages for inflammatory response that reduces reverse cholesterol transport.

  2012cited by this paper
• ER stress is associated with reduced ABCA-1 protein levels in macrophages treated with advanced glycated albumin - reversal by a chemical chaperone.

  2012cited by this paper
• Advanced-glycation-end-product-induced formation of immunoproteasomes: involvement of RAGE and Jak2/STAT1.

  2012cited by this paper
• Trends in the Risk for Coronary Heart Disease Among Adults With Diagnosed Diabetes in the U.S.

  2011cited by this paper
• Trends in the Risk for Coronary Heart Disease Among AdultsWith Diagnosed Diabetes in the U.S. Findings from the National Health and Nutrition Examination Survey, 1999–2008

  2011cited by this paper
• Advanced Glycation in macrophages induces intracellular accumulation of 7-ketocholesterol and total sterols by decreasing the expression of ABCA-1 and ABCG-1

  2011cited by this paper
• Deleterious effects of reactive aldehydes and glycated proteins on macrophage proteasomal function: possible links between diabetes and atherosclerosis.

  2010cited by this paper
• Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.

  2010cited by this paper
• Oxidative stress and diabetic complications.

  2010cited by this paper
• The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes.

  2009cited by this paper
• Chronic Endoplasmic Reticulum Stress Activates Unfolded Protein Response in Arterial Endothelium in Regions of Susceptibility to Atherosclerosis

  2009cited by this paper
• Increased Endoplasmic Reticulum Stress in Atherosclerotic Plaques Associated With Acute Coronary Syndrome

  2007cited by this paper
• The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update.

  2006cited by this paper
• Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products.

  2006cited by this paper
• Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells.

  2005cited by this paper
• Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides

  2004cited by this paper
• The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages

  2003cited by this paper
• Accurate mass measurements by Fourier transform mass spectrometry in the study of advanced glycation end products/peptides.

  2003cited by this paper
• The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes.

  2000cited by this paper
• Direct evaluation of glycated and glyco-oxidized globins by matrix-assisted laser desorption/ionization mass spectrometry.

  1999cited by this paper
• Evaluation of IgG glycation levels by matrix-assisted laser desorption/ionization mass spectrometry.

  1997cited by this paper
• A highly specific method for the characterization of glycation and glyco-oxidation products of globins.

  1997cited by this paper
• Investigations on Protein Nonenzymatic Glycation by a New and Effective Mass Spectrometric Method

  1996cited by this paper
• An electrospray investigation on in vitro glycation of ribonuclease.

  1996cited by this paper
• The in vivo glyco-oxidation of alpha- and beta-globins investigated by matrix-assisted laser desorption/ionization mass spectrometry.

  1996cited by this paper
• A new effective method for the evaluation of glycated intact plasma proteins in diabetic subjects

  1995cited by this paper
• Matrix-assisted laser desorption/ionization mass spectrometric studies on protein glycation. 2. The reaction of ribonuclease with hexoses†

  1994cited by this paper
• Studies on advanced glycation end products by recent mass spectrometric techniques

  1994cited by this paper
• A study on in vitro glycation processes by matrix-assisted laser desorption ionization mass spectrometry.

  1993cited by this paper
• Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

  1976cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• The combined predictive power of the atherogenic index of plasma and serum glycated albumin for cardiovascular events in postmenopausal patients with acute coronary syndrome after percutaneous coronary intervention

  2024cites this paper
• ANALYSIS OF CARBOHYDRATES AND GLYCOCONJUGATES BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION MASS SPECTROMETRY: AN UPDATE FOR 2015-2016.

  2021cites this paper
• Elucidating the Fragmentation Mechanism of Protonated Lewis A Trisaccharide using MSn CID

  2021cites this paper
• Thirty years of fruitful collaborations between a physician and mass spectrometrists in diabetes field.

  2021cites this paper
• Advanced Glycated apoA-IV Loses Its Ability to Prevent the LPS-Induced Reduction in Cholesterol Efflux-Related Gene Expression in Macrophages

  2020cites this paper
• NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists

  2020cites this paper
• NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists

  2020cites this paper
• RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin

  2020cites this paper
• Inflammatory effects of in vivo glycated albumin from cardiovascular patients.

  2019cites this paper
• Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease

  2018cites this paper
• Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis

  2018cites this paper
• The role of mass spectrometry in studies of glycation processes and diabetes management.

  2018cites this paper
• In Vivo Glycated Human Serum Albumin Impairs Cholesterol Efflux from Macrophages

  2017cites this paper
• Maillard Proteomics: Opening New Pages

  2017cites this paper
• Draft 1 Advanced glycation end products affect cholesterol homeostasis by impairing ABCA 1 expression on macrophages

  2017cites this paper
• Advanced glycation end products affect cholesterol homeostasis by impairing ABCA1 expression on macrophages.

  2017cites this paper
• Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.

  2016cites this paper